| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/22/1992 | CN1058018A Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
| 01/21/1992 | US5082857 Antibacterial, antitumor |
| 01/21/1992 | US5082833 Reduction of cell proliferation and enhancement of nk-cell activity |
| 01/21/1992 | CA1294614C Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for producing the same |
| 01/21/1992 | CA1294610C Fluorescent substance, process for producing thereof and cell-discriminating agent containing the same |
| 01/21/1992 | CA1294548C2 Dehydrated liposomes |
| 01/20/1992 | WO1992001456A1 Heterocyclic compounds |
| 01/20/1992 | CA2045231A1 Cell membrane glycoprotein correlated with resistance to platinum-containing antineoplastic agents |
| 01/18/1992 | CA2047138A1 Antitumor compositions and methods of treatment |
| 01/18/1992 | CA2047103A1 Antitumor compositions and methods of treatment |
| 01/17/1992 | CA2047091A1 Method for producing gene protein products |
| 01/15/1992 | EP0466586A1 Disubstituted polymethylene-imines, process for their preparation and pharmaceutical compositions containing them |
| 01/15/1992 | EP0466498A1 Physiologically active peptides having immunoregulatory activities |
| 01/15/1992 | EP0466440A2 Anti-metastatic factor |
| 01/15/1992 | EP0466222A1 Ribosome-inactivating proteins, inactive precursor forms thereof, a process for making and a method of using |
| 01/15/1992 | EP0465529A1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 01/15/1992 | EP0465512A1 Regional chemotherapy with 4-hydroperoxycyclophosphamide. |
| 01/15/1992 | EP0333756B1 1,2-diaminocyclohexane-platinum complexes with antitumor activity |
| 01/15/1992 | EP0232405B1 Soluble phosphorylated glucan |
| 01/14/1992 | US5081271 Novel benzoic acid derivatives and process for preparing the same |
| 01/14/1992 | US5081234 Antitumor agents |
| 01/14/1992 | US5081135 Bactericides |
| 01/14/1992 | US5081124 Amino acid and polyamino acid derivatives, inhibitors of thymidylate synthetase |
| 01/14/1992 | US5081114 Aromatase enzyme inhibitor, cancer therapy |
| 01/14/1992 | US5081107 Bombesin or bombesin-like peptides antagonists; anticarcinogenic agents; antisecretory agents; glandular disorders |
| 01/14/1992 | US5081105 Method of treating cancer using structured lipids |
| 01/14/1992 | US5081034 Genetic engineering |
| 01/12/1992 | CA2046746A1 Disubstituted polymethylene-imines, their preparation process and the pharmaceutical compositions containing such |
| 01/11/1992 | WO1992001055A1 O-glycosylated ifn-alpha |
| 01/11/1992 | CA2084514A1 O-glycosylated ifn-alpha |
| 01/10/1992 | WO1992000995A1 Cyclic cell adhesion modulation compounds |
| 01/10/1992 | CA2087021A1 Cyclic cell adhesion modulation compounds |
| 01/09/1992 | WO1992000330A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 01/09/1992 | WO1992000329A1 Surface complexed lymphotoxin |
| 01/09/1992 | WO1992000327A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(a) |
| 01/09/1992 | WO1992000326A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(b) |
| 01/09/1992 | WO1992000281A1 1,2-dihydro-3h-dibenzisoquinoline-1,3-dione anticancer agents |
| 01/09/1992 | WO1992000086A1 Antitumor agent |
| 01/09/1992 | WO1992000010A1 Method of treating human prostatic adenocarcinoma |
| 01/09/1992 | CA2086091A1 Human macrophage inflammatory protein 2o |
| 01/09/1992 | CA2086088A1 Human macrophage inflammatory protein 2.beta. |
| 01/09/1992 | CA2084510A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 01/08/1992 | EP0465297A1 9-Purinyl phosphonic acid derivatives |
| 01/08/1992 | EP0464656A1 SA3097 compounds, a process for production thereof and use thereof |
| 01/08/1992 | EP0464638A2 Oligonucleotide analogues with terminal 3'-3' or 5'-5'-internucleotide linkages |
| 01/08/1992 | EP0464175A1 Extracellular form of the human fibroblast growth factor receptor |
| 01/08/1992 | CN1057653A Difluoroglutamic acid conjugates with folates and anti-folates for treatment of neoplastic diseases |
| 01/07/1992 | WO1992000738A1 Therapeutic use of piperidine-2,6-diones |
| 01/07/1992 | US5079358 Humans; leukemia |
| 01/07/1992 | US5079262 Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid |
| 01/07/1992 | US5079257 Antitumor Agents |
| 01/07/1992 | US5079233 N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same |
| 01/07/1992 | US5078996 Genetic engineering, anticancer agents |
| 01/07/1992 | CA2086260A1 Therapeutic use of piperidine-2,6-diones |
| 01/06/1992 | CA2044636A1 Guanidines |
| 01/02/1992 | EP0463811A2 4-(4-Chlorophenylsulphonylcarbamoyl)benzoyl-L-valyl-L-proline-1-(RS)-(1-trifluoroacetyl-2-methylpropyl)amide for treating haemorrhage associated with acute non-lymphocytic leukaemia |
| 01/02/1992 | EP0463037A1 Human macrophage migration inhibitory factor |
| 01/02/1992 | EP0462980A1 Platinum pharmaceutical agents |
| 01/02/1992 | EP0462964A1 Treatment of skin diseases and tumors |
| 01/02/1992 | EP0451299A4 Magnetocontrollable carrier with physiologically active substance and method for making said carrier |
| 12/31/1991 | US5077302 Urea derivatives |
| 12/31/1991 | US5077298 Administering neuroleptic agents |
| 12/31/1991 | US5077276 Growth factor |
| 12/31/1991 | US5077211 Purification and administration of dna repair enzymes |
| 12/31/1991 | US5077055 Topical therapeutic system comprising 5-fluorouracil |
| 12/31/1991 | CA1293735C Rooperol and its derivatives |
| 12/28/1991 | WO1992000099A1 Method of introducing a peptide into the cytosol |
| 12/28/1991 | CA2086342A1 Method of introducing a peptide into a cytosol |
| 12/27/1991 | EP0462935A1 Enantiomers of 2-tetrahydrofuran derivatives, intermediates therefor and their preparation |
| 12/27/1991 | EP0462787A1 Radiopharmaceutical formulations, their method of administration and process of preparation |
| 12/27/1991 | EP0462398A1 TGF-beta compositions |
| 12/27/1991 | EP0462305A1 Aerosol containing cytokines and use thereof |
| 12/27/1991 | EP0462206A1 Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles |
| 12/27/1991 | EP0462179A1 Novel sulfonamides as radiosensitizers |
| 12/26/1991 | WO1991019716A1 Antitumor substance be-13793c |
| 12/26/1991 | WO1991019713A1 Pyrimidine nucleoside derivative |
| 12/26/1991 | WO1991019700A1 Pharmaceutically active benzoquinazoline compounds |
| 12/26/1991 | WO1991019514A1 An anticoagulant preparation |
| 12/26/1991 | WO1991017773A3 New protein-polycation conjugates |
| 12/26/1991 | CA2085101A1 An anticoagulant preparation |
| 12/26/1991 | CA2045294A1 Agent for therapy |
| 12/24/1991 | US5075454 Chemical intermediate, antitumor agent |
| 12/24/1991 | US5075423 Purification of protein a by affinity chromatography followed by anion exchange |
| 12/23/1991 | CA2044908A1 In vivo targeting with bifuncitonal antibodies |
| 12/22/1991 | CA2044858A1 Method of treating bladder cancer cells |
| 12/22/1991 | CA2043992A1 Use of cytokine-containing aerosols and the cytokine-containing aerosols |
| 12/21/1991 | WO1991019707A2 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
| 12/21/1991 | CA2081577A1 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1, 3-benzoxazine-4-ones |
| 12/20/1991 | CA2044786A1 Enantiomers of 2-tetrahydrofuran derivatives, intermediates, therefor, and their preparation |
| 12/19/1991 | WO1991019736A2 Cancer-associated scm-recognition factor, preparation and method of use |
| 12/19/1991 | CA2084767A1 Cancer-associated scm-recognition factor, preparation and method of use |
| 12/18/1991 | EP0461869A2 Chemotherapeutic agents |
| 12/18/1991 | EP0461556A1 Epipodophyllotoxin glycosides |
| 12/18/1991 | EP0461407A1 Improved process for the preparation of 2-amino(2,3,5-tri-O-benzyl-beta-D-arabinofuranosyl)adenine |
| 12/18/1991 | EP0461245A1 Radiolabeled proteins for diagnostic or therapeutic use |
| 12/18/1991 | EP0461237A1 Use of 9,10-dihydrophenanthrene derivatives to prepare an antitumoral drug, and novel derivatives thereof. |
| 12/18/1991 | EP0461225A1 Circumvention of human tumor drug resistance |
| 12/18/1991 | EP0288534B1 Compositions of catecholic butanes with zinc |
| 12/18/1991 | CN1057049A Method for preparation of taxol |
| 12/17/1991 | US5073541 Treatment of small cell lung cancer with somatostatin analogs |